Medically prescribed products containing THC have shown value and safety in the management of a number of important clinical conditions, including debilitating chronic pain. Emyria who have seen over 3500 patients upholds evidence-based investigation and pharmacovigilance. Many patients are unfairly prohibited from access to these products by out-of-date driving legislation and testing that is not evidence-based. We need to Drive Change to prohibit driving with impairment, not driving with improvement.
Answering Cannabis Law FAQ
With cannabis available via a prescription in Australia since 2016, both doctors and patients are increasingly more likely to consider it as part of a healthcare practice. Medicinal cannabis is already widely prescribed for conditions including PTSD, chronic pain, anxiety, and insomnia. Although the health industry generally agrees with its medicinal merits, the driving laws […]Read more
Dr Teresa Towpik: “Ignorance Isn’t Bliss, Knowledge Is.”
This article is written by Drive Change ambassador Dr. Teresa Towpik. Below, she shares her experience with the drug driving laws from the standpoint of a medicinal cannabis doctor and patient. January 2016–what a month it was for me. I didn’t realise it then, but this would mark the beginning of a new chapter in […]Read more